Journal of ovarian research · 2025
IVF and pregnancy outcomes: the triumphs, challenges, and unanswered questions.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bentov Yaakov, Schenker Joseph
Аннотация
BACKGROUND: In vitro fertilization (IVF) has become an integral component of reproductive medicine, providing a pathway to parenthood for infertile and sub-fertile couples. Currently, IVF accounts for approximately 2-5% of all births globally. Over the past decades, the field has witnessed substantial advancements, including changes in patient demographics, embryology techniques, pharmaceutical agents, and treatment protocols.
METHODS: This review examines the evolution of IVF, focusing on technological innovations and shifting patient profiles, particularly the increasing number of older women undergoing treatment.
RESULTS: While technological and clinical innovations have enhanced IVF success rates and safety, they have also contributed to a broader patient population, including women with pre-existing medical conditions. These divergent trends-improved treatment efficacy alongside growing medical complexity-have reshaped the clinical and public health risk profiles associated with IVF.
CONCLUSIONS: Ongoing surveillance, comprehensive patient counseling, and appropriate regulatory oversight are essential to sustaining high-quality reproductive care in the context of a continually evolving IVF landscape.
METHODS: This review examines the evolution of IVF, focusing on technological innovations and shifting patient profiles, particularly the increasing number of older women undergoing treatment.
RESULTS: While technological and clinical innovations have enhanced IVF success rates and safety, they have also contributed to a broader patient population, including women with pre-existing medical conditions. These divergent trends-improved treatment efficacy alongside growing medical complexity-have reshaped the clinical and public health risk profiles associated with IVF.
CONCLUSIONS: Ongoing surveillance, comprehensive patient counseling, and appropriate regulatory oversight are essential to sustaining high-quality reproductive care in the context of a continually evolving IVF landscape.